Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes

Molecular Pharmacology

Volumn 49, Issue 2, 1996, Pages 260-268

  Carpenter, Susan P ^a   Lasker, Jerome M ^b   Raucy, Judy L ^a,c  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c AGOURON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYTOCHROME P450;

ARTICLE; ENZYME ACTIVITY; ENZYME INDUCTION; FETUS; FETUS LIVER; HUMAN; HUMAN CELL; LIVER CARCINOMA; LIVER METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030051333     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Hanson, J. W., and D W. Smith. The fetal hydantoin syndrome. J Pediatr. 87:285-290 (1975).
2. McBride, W. G. Thalidomide and congenital anomalies. Lancet 2:1358-1361 (1961).
3. Bjerkedal, T., A. Czeizel, J. Goujard, B Kallen, P. Mastroicova, N. Nevin, G. Oakley, and E. Robert. Valproic acid and spina bifida. Lancet 2:1096-1099 (1982).
4. Jones, K. L., and D. W. Smith. Recognition of the fetal alcohol syndrome in early infancy. Lancet 2:999-1001 (1973)
5. Abel, E. L , and R. J. Sokol. Incidence of fetal alcohol syndrome and economic impact of FAS-related anomalies. Drug Alcohol Depend. 19: 51-70 (1987).
6. Raucy, J. L., and S. J. Carpenter. The expression of xenobiotic-metabolizing cytochromes P450 in fetal tissues. J. Pharmacol. Toxicol. Methods 29:121-128 (1993).
7. Wrighton, S. A., D. T. Molowa, and P. S. Guzehan. Identification of a cytochrome P450 in human fetal liver related to glucocorticoid-inducible cytochrome P450HLp in the adult. Biochem. Pharmacol. 37:3053-3055 (1988).
8. Schuetz, J. D., D. L. Beach, and P. S. Guzelian. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4:11-20 (1994).
9. Krauer, B., and P. Dayer. Fetal drug metabolism and its possible clinical implications. Clin. Pharmacokinet. 21:70-80 (1991).
10. Raucy, J. L., J. M. Lasker, C S. Lieber, and M. Black. Acetaminophen activation by human liver cytochromes P450IIE1 and P4501A2. Arch. Biochem Biophys. 271:270-283 (1989).
11. Johansson, I., and M. Ingelman-Sundberg. Carbon tetrachloride-induced lipid peroxidation dependent on an ethanol-inducible form of rabbit liver microsomal eytochrome P450. FEBS Lett. 183:265-270 (1985).
12. Yang, C. S., J. S. H. Yoo, H. Ishizaki, and J. Hong. Cytochrome P450IIE1 roles of nitrosamine metabolism and mechanisms of regulation. Drug Metab. Rev. 22:147-153 (1990).
13. Bartsch, H., and R. Montesano. Relevance of nitrosamines to human cancer. Carcinogenesis 5:1381-1393 (1984).
14. Lasker, J. M., J. L. Raucy, S. Kubota, B. P. Bloswick, M. Black, and C. S. Lieber. Purification and characterization of human liver cytochrome P450ALC. Biochem. Biophys. Res. Commun. 148:232-238 (1987).
15. Lieber, C. S. Metabolic effects of acetaldehyde. Biochem Soc. Trans. 16: 241-247 (1988).
16. Ristow, H , A. Seyfarth, E-R. Lochmann. Chromosomal damages by ethanol and acetaldehyde in Saccharomyces cerevisiae as studied by pulsed field gel electrophoresis. Mutat. Res. 326:165-170 (1995).
17. Albano, E., A. Toamsi, J. O. Persson, Y. Terelius, L. Goria-Gatti, M. Ingelman-Sundberg, and M. U. Dianzani. Role of ethanol-inducible cytochrome P450 (P450IIE1) in catalysing the free radical activation of aliphatic alcohols. Biochem. Pharmacol. 41:1895-1902 (1991).
18. Ekstrom, G., and M. Ingelman-Sundberg. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P450. Biochem. Pharmacol. 38:1813-1819 (1989).
19. Raucy, J. L , and J. M. Lasker. Isolation of P450 enzymes from human liver. Methods Enzymol. 206:577-587 (1991).
20. Bensadoun, A., and D. Weinstein. Assay of proteins in the presence of interfering materials. Anal. Biochem. 92:497-500 (1976).
21. Takahashi, T., J. M. Lasker, A. S. Rosman, and C. S. Lieber. Induction of P4502E1 in human liver by ethanol is due to a corresponding increase in encoding mRNA. Hepatology 17:236-245 (1993).
22. Chomczyski, P., and Sacchi, N. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159 (1987).
23. Sanger, F., S. Nicklen, and A. R. Colson. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467 (1987).
24. Song, B.-J., H. V. Gelboin, S.-S. Park, C. S. Yang, and F. J Gonzalez. Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P450s. J. Biol. Chem. 261:16689-16697 (1986).
25. Ardies, C. M., J. M. Lasker, and C. S. Lieber. Characterization of the cytochrome P450-dependent monooxygenase system of hamster liver microsomes: effects of prior treatment with ethanol and other xenobiotics. Biochem Pharmacol. 36:3613-3619 (1987).
26. Mathis, J. M., R. A. Prough, and E. R Simpson. Synergistic induction of monooxygenase activity by glucocorticoids and polycyclic aromatic hydrocarbons in human fetal hepatocytes in primary monolayer culture. Arch. Biochem. Biophys. 244:650-661 (1986).
27. Raucy, J. L., M. Black, C. S Lieber, and J. M. Lasker. The ethanol-inducible cytochrome P450 in man can activate N-nitrosodimethylamine and acetaminophen. Hepatology 8:1279 (1988).
28. Muerhoff, A. S., K. J. Griffin, and E. F. Johnson. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid ω-hydroxylase, by clofibric acid. J. Biol. Chem. 267:19051-19053 (1992).
29. Raucy, J L., J. C. Kraner, and J. M. Lasker. Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit Rev. Toxicol. 23:1-20 (1993).
30. Cresteil, T., P. Beaune, P Kremers, C. Celies, F P. Guengerich, and J. P. Leroux. Immunoquantitation of epoxide hydroxylase and cytochrome P450 isozymes in fetal and adult liver microsomes. Eur. J. Biochem. 151:345-350 (1985).
31. Komori, M., K. Nishio, T. Fujitani, H. Mitsukazu, K. Satoakimima, K. Itahashi, and T. Kamataki. Isolation of a new human fetal liver cytochrome P450 cDNA clone, evidence for expression of a limited number of forms of cytochrome P450 in human fetal livers. Arch. Biochem. Biophys. 272:219-225 (1989).
32. Jones, S. M., A. R Boobis, G. E. Moore, and P Stainer Expression of CYP2E1 during human fetal development: methylation of the CYP2E1 gene in human fetal and adult liver samples. Biochem. Pharmacol. 43: 1876-1879 (1992).
33. Eliasson, E., I. Johansson, and M. Ingelman-Sundberg. Substrate-, hormone-, and cAMP-regulated cytochrome P450 degradation. Proc. Natl Acad. Sci. USA 87:3225-3229 (1990).
34. Armstrong, R. N., C Pinto-Coelho, D. E. Ryan, P. E. Thomas, and W. Levin. On the glycosylation state of five rat hepatic microsomal cytochrome P450 enzymes. J. Biol. Chem. 258:2106-2108 (1983)
35. Sethumadhavan, K., F. L. Bellino, and N. R. Thotakura. Estrogen synthetase (aromatase): the cytachrome P450 component of the human placental enzyme is a glycoprotein. Mol. Cell. Endocrinol. 78:25-32 (1991).
36. Pikkarainen, P. H. Metabolism of ethanol and acetaldehyde in perfused human fetal liver. Life Sci. 10:1359-1364 (1971).
37. Wrighton, S. A., and J C. Stevens. The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 22:1-21 (1992).
38. Wortelboer, H. M., C A. De Kruf, and A. A. J. Van Lersel. Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures: the effect of model inducers on apoproteins and biotransformation activities. Biochem. Pharmacol. 42:381-390 (1991).
39. Kraner, J. C., J. M. Lasker, G. E. Corcoran, S. D. Ray and J. L. Raucy. Induction of P4502E1 by acetone in isolated rabbit hepatocytes: role of increased protein and mRNA synthesis Biochem. Pharmacol. 45:1483-1492 (1993).
40. Miller, M. S., S. P. Warner, R. Jorquera, A. Castonguay, and H. M. Schuller. Expression of the cytochrome P4502E1 and 2B gene families in the lungs and livers of nonpregnant, pregnant, and fetal hamsters. Biochem. Pharmacol 44:797-803 (1992).
41. Lieber, C. S. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N. Engl. J Med. 319:1639-1650 (1988).
42. West, J. R Fetal alcohol-induced brain damage and the problem of determining temporal vulnerability: a review. Alcohol Drug Res. 7:423-441 (1987).
43. Laethem, R M., M. Balazy, J. R. Falck, C. L. Laethem, and D. R. Koop. Formation of 19(S)-:19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P4502E1. J. Biol. Chem. 268:12912-12918 (1993).